Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-09

Clinical Trial Update: Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)

View source ↗

Summary

Clinical trial update indicating inherited genetic susceptibility in Langerhans cell histiocytosis (LCH); the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Oncology Group | Conditions: Histiocytosis, Langerhans-Cell | Status: ACTIVE_NOT_RECRUITING